Austrianova is one company that does services that contains high tech, life sciences and biotech

Austrianova is one business that does businesses that comprises high tech, life sciences and biotech. It is complemented with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science congregatedcombined organization that concentrate in the insertion of living cells or bacteria in small casings for protection which is also regarded as cell encapsulation technology, isolation, storage and transportation. We were first established in the year 2007 and was based in Singapore's best investigation biotech hub, Biopolis that has international goal in having encapsulation services like micro encapsulation.

There is a quick increasing topic of attention in healthy attention and more detailed, in the area of neutraceuticals which is the understanding and use of probiotic bacteria. Therefore, probiotics encapsulation was formed. The cell-in-a-box technology was developed by Austranova with the target to defend, cut off, store and transfer living cells. This proprietary finding can be used for numerous purposes and can be operated to probiotics, cosmetics and agriculture environmental protection and monitoring as well as creating the root of a influential research device.

In healthcare, this technology supports facilitates secure implantation of cells or stem cells such as cell therapy, holding them keep away from the immune system and enabling long stage construction of therapeutic molecules in patients. In biotechnology, the cell-in-a-box technology guards cells in bioreactors and fermentors and at the same time, it shorten refining of bioproducts manufactured from the cells and it cut down manufacture rate too.

A wide ruler cGMP facility for the construction of biomedical grade encapsulated cell products was beforehand successfully formed and right now, Austrianova is in the development of developing this skill in the whole of SE Asia. This means the use of cell-in-a-box was quite a accomplishment for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to allow lesser dosages of chemotherapy to be used more effectually without the normal debilitating side results. The encapsulated cell are placed, using supraselective catheterisation, into blood vessels that drives to the tumor where they locally convert a chemotherapeutic product to its tumor toxic product.

Visit our site for more details: Stem Cells, Capsules , Cell Encapsulation Technology.